CytoSorbents Corp. (CTSO)
0.411
-0.01
(-2.72%)
USD |
NASDAQ |
Jun 10, 16:00
0.4125
0.00 (0.00%)
Pre-Market: 20:00
CytoSorbents Debt to Equity Ratio : 13.47 for March 31, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2026 | 13.47 |
| December 31, 2025 | 4.978 |
| September 30, 2025 | 3.040 |
| June 30, 2025 | 2.360 |
| March 31, 2025 | 1.873 |
| December 31, 2024 | 2.421 |
| September 30, 2024 | 2.062 |
| June 30, 2024 | 1.599 |
| March 31, 2024 | 0.9304 |
| December 31, 2023 | 0.7799 |
| September 30, 2023 | 0.9746 |
| June 30, 2023 | 0.7518 |
| March 31, 2023 | 0.628 |
| December 31, 2022 | 0.5159 |
| September 30, 2022 | 0.342 |
| June 30, 2022 | 0.284 |
| March 31, 2022 | 0.2464 |
| December 31, 2021 | 0.2209 |
| September 30, 2021 | 0.1933 |
| June 30, 2021 | 0.1783 |
| March 31, 2021 | 0.012 |
| December 31, 2020 | 0.013 |
| September 30, 2020 | 0.2031 |
| June 30, 2020 | 0.6725 |
| March 31, 2020 | 0.7534 |
| Date | Value |
|---|---|
| December 31, 2019 | 4.717 |
| September 30, 2019 | 2.404 |
| June 30, 2019 | 0.975 |
| March 31, 2019 | 0.7542 |
| December 31, 2018 | 0.587 |
| September 30, 2018 | 0.4941 |
| June 30, 2018 | 0.4589 |
| March 31, 2018 | 0.6832 |
| December 31, 2017 | 0.9736 |
| September 30, 2017 | 1.052 |
| June 30, 2017 | 1.256 |
| March 31, 2017 | -3.137 |
| December 31, 2016 | 3.672 |
| September 30, 2016 | 3.552 |
| June 30, 2016 | 1.253 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.0836 |
| March 31, 2014 | -0.2379 |
| December 31, 2013 | 1.677 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ClearPoint Neuro, Inc. | 3.375 |
| Abbott Laboratories | 0.654 |
| AngioDynamics, Inc. | 0.0657 |
| Alphatec Holdings, Inc. | 33.03 |
| AtriCure, Inc. | 0.1524 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 40.56M |
| Total Liabilities (Quarterly) | 38.37M |
| Shareholders Equity (Quarterly) | 2.194M |
| Current Ratio | 1.089 |
| Net Debt Paydown Yield | -1.49% |